Brief: Vaccinex Posts Q3 Revenue Of $404,000 Vs $198,000
12/11/2019 13:44
Nov 12 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* Q3 REVENUE $404,000 VERSUS $198,000
* Q3 REVENUE ESTIMATE $33,300 -- REFINITIV IBES DATA
* VACCINEX - CASH & CASH EQUIVALENTS, MARKETABLE SECURITIES,
&
ACCOUNTS RECEIVABLE ON SEPT 30 WERE $9.7 MILLION
Source text for Eikon: ID:nGNXb20PWJ
Further company coverage: VCNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease